Screen Reader Mode Icon

Question Title

* 1. 48-yr-woman presents for restaging of lymphoma after chemotherapy. She has a history of skin itching and hives after contrast CT last time. What is the next best step.

Question Title

* 2. 52-year-woman with history of breast cancer treated 5 years back and gall stones. Now presents with acute right upper abdominal pain and fever. What is the next best imaging test?

Question Title

* 3. If a patient is randomized to a placebo arm on study they will receive less treatment than the standard of care?

Question Title

* 4. What type of research is most commonly seen/used in Oncology treatment?

Question Title

* 5. Which phase of research includes about 200 patient's and focuses on checking for efficacy?

Question Title

* 6. Which Oncologic Emergency is referenced by the following phrase: “Stones, Bones, Moans, Groans, Thrones, Psychiatric Overtones”?

Question Title

* 7. A 50 year old patient with metastatic breast cancer presents with an onset of back pain, motor weakness and decreased buttocks sensation. You are concerned about spinal cord compression. You give her Dexamethasone 10 mg IV x 1. What is the next step that you would do?

Question Title

* 8. Which oncologic emergency is characterized by hyperuricemia, hyperkalemia, hypocalcemia and renal failure?

Question Title

* 9. XY is a 60 y/o female with Stage IV TNBC and showed PD-L1 > 1%. She was recently started on atezolizumab 840 mg Days 1 and 15 alongside nab-PACLitaxel 100 mg/m2 Days 1,8, and 15 every 28 days. What side effects concern you and how would you monitor?

Question Title

* 10. BW is a 70 y/o male recently with an unresectable nodal melanoma lesion recurrent after initial surgery. He will be started on talimogene laherparepvec. What precautions would you recommend BW to take while receiving this therapy?

Question Title

* 11. WW is a 67 y/o male that was recently diagnosed with advanced non squamous NSCLC w PD-L1 expression ≥ 1% and EGFR/ALK negative. His oncology team started him on atezolizumab 1,200 mg, bevacizumab 15 mg/kg, PACLitaxel 200 mg/m2, and CARBOplatin AUC 6 every 21 days for 4 cycles. What side effects concern you and how would you monitor?

Question Title

* 12. What treatment is FDA approved for newly diagnosed FLT 3+ acute myeloid leukemia?

Question Title

* 13. Which drug below is approved for newly diagnosed CD38+ multiple myeloma?

0 of 13 answered
 

T